SPINAL OSTEOCHONDROSIS · OSTEOCHONDRITIS · SCHEUERMANN'S DISEASE
A physician-led, laboratory-verified treatment programme targeting disc-vertebral degeneration, endplate damage and chronic spinal inflammation — tailored to the individual anatomy, disease stage and functional status of each patient.
Request Medical ConsultationAbout the Condition
Osteochondrosis is a degenerative condition affecting the vertebral endplates, intervertebral discs and surrounding bone-cartilage interface. Unlike simple disc herniation, osteochondrosis involves structural breakdown of the disc-vertebral junction itself — leading to chronic pain, progressive loss of spinal mobility and segmental instability.
The condition most commonly affects the lumbar and cervical spine, though thoracic involvement (Scheuermann's disease) represents a distinct clinical entity with vertebral wedging and kyphotic deformity. Osteochondritis dissecans — a related process in peripheral joints — involves focal cartilage-bone separation with similar degenerative mechanisms.
Conservative management (physiotherapy, analgesics, epidural injections) addresses symptoms but does not reverse endplate erosion or restore disc-vertebral integrity. Surgical intervention carries significant risks and recovery burden. Our programme targets the biological mechanisms driving degeneration at the cellular level.
Cervical Osteochondrosis
Degenerative changes in the C3–C7 vertebral segments affecting disc height, endplate integrity and foraminal dimensions. Presents with neck pain, cervicogenic headache, upper limb radiculopathy and restricted rotation. Progression may compromise vertebral artery flow and cervical cord function.
Thoracic Osteochondrosis (Scheuermann's Disease)
Structural vertebral wedging in the thoracic spine, typically affecting T7–T10. Results in increased kyphosis, interscapular pain, reduced thoracic mobility and postural deformity. Most commonly diagnosed in adolescence but symptomatic deterioration often continues into adulthood.
Lumbar Osteochondrosis
The most prevalent form, affecting L3–S1 segments. Characterised by disc desiccation, endplate Modic changes, facet hypertrophy and segmental instability. Presents with chronic low back pain, morning stiffness, reduced flexion-extension range and, in advanced cases, neurogenic claudication.
Osteochondritis Dissecans (Joint)
Focal separation of articular cartilage and subchondral bone, most commonly in the knee, ankle or elbow. Results in joint pain, mechanical locking, effusion and progressive cartilage loss. Shares degenerative and vascular mechanisms with spinal osteochondrosis.
Our program is individually adapted for all subtypes and all stages of progression.
Important: Each patient is accepted into the programme only after a comprehensive individual medical assessment, which evaluates imaging findings, pain chronicity, neurological status, spinal stability and overall clinical profile.
We do not offer a cure for structural spinal degeneration. Our programme targets the biological processes driving endplate erosion, disc-vertebral breakdown and chronic inflammation — with the clinical objective of reducing pain, restoring functional mobility and slowing further deterioration.
Clinical Outcomes
The following data are derived from structured observational analysis of patients treated at BioCells Medical between 2016 and 2025. All figures represent aggregated clinical registry outcomes with longitudinal follow-up. These are observational results — not randomised controlled trial data — and do not constitute a guarantee of therapeutic effect.
30
osteochondrosis patients treated
76%
demonstrated measurable pain reduction and functional improvement within 2–4 months
70%
showed improvement in at least one functional domain (mobility, pain, daily activity)
−2.4 pts
average VAS pain score reduction at 4-month follow-up
63%
achieved clinically meaningful ODI/NDI improvement (≥10-point reduction)
68%
maintained sustained functional benefit — follow-up to 2 years
Reduced chronic spinal pain at rest and during movement
74%
Improved spinal range of motion (flexion, extension, rotation)
67%
Reduction in paravertebral muscle spasm and guarding
71%
Improved capacity for daily activities (walking, sitting tolerance, lifting)
63%
Reduced analgesic dependency
58%
2–4 weeks
Initial functional response
2–4 months
Clinically meaningful change
1–2 years under continued monitoring
Sustained functional benefit
Important: Outcomes depend on disease stage, number of affected segments, presence of Modic changes, baseline pain chronicity and individual biological response. Individual results may vary significantly.
Find out if our program can help in your specific case. The initial medical consultation is free and carries no obligation.
Request ConsultationPatient Stories
“Eight years of lumbar pain. Physio would help for a week, then it came back. After treatment I noticed the change gradually. One morning I walked the dog for forty minutes without stopping. The stiffness that used to take half my morning just faded. My orthopaedic surgeon in Istanbul said my range of motion was the best he had measured in years.”
Patient
Lumbar osteochondrosis (L4–L5, L5–S1) · Turkey
Every case is assessed individually by our physician team. Request a consultation to discuss your specific situation with our physician team.
Request ConsultationThe BioCells Program
Our osteochondrosis programme combines five biological components into a single personalised protocol. No two protocols are identical — each is constructed following a detailed medical evaluation of the patient's spinal imaging, pain profile, functional status and clinical priorities.
No surgery required
Treatment is delivered by intravenous infusion or targeted local injection — not by surgical instrumentation, fusion hardware or disc implants.
No general anaesthesia
All procedures are performed under local anaesthesia or without anaesthesia entirely. Patients remain conscious throughout.
No risk of immune rejection — autologous option
Where clinically appropriate, we use the patient's own cells. Zero risk of graft-versus-host disease with autologous protocols.
Targets the degenerative biology, not just pain
Rather than masking symptoms with analgesics or steroid injections, our protocol targets endplate erosion, disc-vertebral inflammation and cartilage breakdown — the biological drivers of osteochondrosis progression.
Complements existing treatment
Our programme is compatible with ongoing physiotherapy, pain management and any prescribed medication. Patients do not need to discontinue existing treatment before commencing our protocol.
Treatment at your location worldwide
Our medical team is available to conduct treatment at our Warsaw clinic or to travel to the patient's location anywhere in the world. For patients with severe mobility limitation, this removes a major barrier to accessing care.
What It Is
MSCs are multipotent regenerative cells with established anti-inflammatory and tissue-repair properties. In spinal degeneration, they represent the most extensively studied cell type for disc and cartilage regeneration, with demonstrated safety across thousands of clinical applications.
How It Is Done
Cells are collected from the patient's own bone marrow (autologous, approximately 50 ml under local anaesthesia) or sourced from a certified donor (allogeneic), depending on individual clinical indications. All cells are expanded, quality-controlled and tested in our certified Warsaw laboratory before administration.
Biological Mechanisms
How This Helps in Osteochondrosis
In osteochondrosis, the vertebral endplate loses its vascular supply and the disc-bone interface progressively breaks down. MSCs address this by promoting local tissue repair, suppressing the inflammatory cascade that accelerates cartilage erosion, and supporting the biological conditions needed for endplate and disc stabilisation.
Your Medical Board
The exact combination, dosage, sequencing and delivery method of all five components is determined individually by our medical board for each patient. No two treatment protocols are identical. Your programme is constructed based on your specific diagnosis, affected spinal segments, imaging findings, pain profile and clinical priorities.
Your protocol is designed individually. Speak with our medical team to understand what your personalised program would include.
Request ConsultationPatient Journey
Your case is reviewed remotely by our physician team. We assess your diagnosis, spinal imaging, pain history and treatment goals. This consultation is free and carries no obligation.
A detailed review of all medical documentation including MRI findings, pain chronicity and functional assessments. Our medical board evaluates eligibility, confirms safety parameters and designs your personalised therapeutic protocol.
Your cells are collected, isolated, expanded and quality-tested in our certified Warsaw laboratory. Each batch receives a full traceability certificate. This stage typically takes 2–3 weeks.
Cells are delivered by intravenous infusion or targeted local administration to affected spinal segments — no general anaesthesia required. Treatment is available at our Warsaw clinic or with our medical team at your location worldwide. Airport transfers, accommodation and visa support are included in the programme.
Structured rehabilitation sessions with our specialist, adapted to your current spinal mobility, pain status and functional capacity. Includes spinal stabilisation training, postural correction and graded return to activity. Available at our clinic or remotely coordinated with your local medical team.
Your dedicated coordinator monitors pain status, functional progress and spinal stability. A medical-grade wearable bracelet supports continuous health tracking regardless of your location. Follow-up imaging is scheduled to assess structural response.
The first step is free. Request a medical consultation and our medical consultant will contact you within 24 hours.
Request ConsultationSafety Profile
Cellular therapy is considered safe when delivered under proper medical supervision and according to validated protocols. In our practice, the procedure is well-tolerated by the majority of osteochondrosis patients.
Temporary mild reactions — such as transient local discomfort at the injection site, slight fatigue or low-grade temperature — may occur in a minority of patients. These are typically short-lived and indicate active biological engagement.
A final medical assessment is performed on-site before every treatment session. If a patient's status has changed — including acute neurological deterioration — the programme may be temporarily modified or postponed for safety reasons.
All contraindications are evaluated individually. A contraindication in one clinical context does not necessarily preclude treatment in a different context — this is always determined by physician assessment.
Standard Contraindications
Active acute infection or fever
Active malignancy or ongoing chemotherapy / radiotherapy
Severe decompensated cardiac or renal failure
Pregnancy
Acute spinal cord compression requiring emergency surgical intervention
Post-Treatment
Dedicated rehabilitation specialist
monitors spinal function, pain status and movement quality
Personalised rehabilitation programme
spinal stabilisation, postural correction and graded functional progression
Medical-grade wearable monitoring
continuous physiological data collection supporting clinical decision-making
Long-term coordinator support
proactive check-ins, clinical guidance and response to any changes in status
Continued clinical access
our medical team remains available for ongoing reassessment, follow-up imaging review and protocol adjustment
Spinal tissue regeneration operates on a biological timeline that extends well beyond the treatment period. Disc and endplate repair is gradual, and clinical gains often continue to develop over months. Structured follow-up and rehabilitation adherence are essential to achieving and maintaining optimal results.
Get Started
If you are living with spinal osteochondrosis, chronic back or neck pain, or a related degenerative condition, our medical team is available for a free, no-obligation medical consultation — based on your diagnosis, imaging findings and individual clinical profile.
We review every inquiry personally. You will speak with a physician, not an administrator.
Submit your case online or by phone
Our medical consultant contacts you to review your documents
The medical board presents your personalised treatment plan
Request a Consultation
Tell us about your condition. Our medical consultant will contact you within 24 hours to review your documents.
Open Consultation FormMultilingual coordination — English, Italian, French, Russian, Polish
Evidence Base
Our clinical approach is informed by and consistent with published research in the field of regenerative medicine.
